Over 10 years we help companies reach their financial and branding goals. Maxbizz is a values-driven consulting agency dedicated.

Gallery

Contact

+1-800-456-478-23

411 University St, Seattle

maxbizz@mail.com

the street news image

Pfizer-BioNTech Children’s Covid-19 Vaccine Secures FDA Approval

The Food and Drug Administration on Friday authorized emergency use of Pfizer  (PFE) – Get Pfizer Inc. Report and BioNTech’s  (BNTX) – Get BioNTech SE Sponsored ADR Report Covid-19 vaccine for children ages 5 through 11. The Pfizer-BioNTech vaccine, which is the first Covid-19 vaccine authorized in the U.S. for children ages 5 through 11, will be administered…

the street news image

Entrada Therapeutics Announces Pricing Of Upsized Initial Public Offering

BOSTON, Oct. 28, 2021 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company aiming to transform the lives of patients by establishing Endosomal Escape Vehicle (EEV™) therapeutics as a new class of medicines and aiming to become the world’s foremost intracellular therapeutics company, today announced the pricing of its upsized initial public offering…

the street news image

Safety, Comfort, And Anticipation: Creating Safe Smart Spaces After COVID-19

NEW YORK, Oct. 28, 2021 /PRNewswire/ — Smartization, or smart transformation, has become a hot topic for individuals, enterprises, and society as a whole. The uncertainty in the early stages of the pandemic caused companies to rethink their existing business models, supply chains, production processes, and working environments. Emerging technologies, including but not limited to…

the street news image

CATL And Hyundai MOBIS Sign CTP Technology Licensing And Partnership Agreement

CATL shares its CTP (cell to pack) technology with MOBIS through the agreement. The agreement also includes related CTP products supply in South Korea and the global market. The technology partnership helps both parties sharpen their competitive edge on the international market. NINGDE, China, Oct. 27, 2021 /PRNewswire/ — Contemporary Amperex Technology Co., Ltd. (CATL) and…

the street news image

Evaxion Biotech Announces Filing Of Registration Statement In The U.S For Proposed Follow-on Public Offering To Raise Additional Capital

COPENHAGEN, Denmark, Oct. 26, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (Nasdaq: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer, bacterial diseases and viral infections, announced today that it has filed a registration statement on Form F-1 (the “Registration…